Pharmaceutical compositions for prevention and treatment of menopausal symptom of women containing Flemingia strobilifera or its isolated compound as an active ingredient
The present invention relates to a pharmaceutical composition for prevention and treatment of menopausal symptom of women and female cancer, which contains a Flemingia strobilifera extract, an active fraction or a single component isolated therefrom, and pharmaceutically acceptable salt thereof as a...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a pharmaceutical composition for prevention and treatment of menopausal symptom of women and female cancer, which contains a Flemingia strobilifera extract, an active fraction or a single component isolated therefrom, and pharmaceutically acceptable salt thereof as an active ingredient. The present invention is the first to confirm that the Flemingia strobilifera extract, an active fraction thereof, and the single component derived therefrom exhibit properties of female hormones. The female hormone substances provided by the present invention can be used in the field of medicines and health functional food for the treatment and prevention of female cancer and menopausal symptoms.
본 발명은 플레밍기아 스트로빌리페라() 추출물, 이의 활성분획 또는 이로부터 분리한 단일 성분들 및 이들의 약학적으로 허용 가능한 염을 유효성분으로 함유하는, 여성암 및 갱년기 증상의 예방 및 치료용 약학적 조성물에 관한 것이다. 본 발명은 플레밍기아 스트로빌리페라 추출물, 이의 활성분획 및 이로부터 유래된 단일 성분들이 여성호르몬성을 나타낸다는 것을 처음으로 확인한 것으로, 본 발명에서 제공하는 여성호르몬성 물질들은, 여성암과 갱년기 증상의 치료 및 예방을 위해 의약품과 건강기능성 식품 분야에서 이용될 수 있다. |
---|